Your new experience awaits. Try the new design now and help us make it even better

MINI REVIEW article

Front. Pharmacol.

Sec. Neuropharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1702862

Dexmedetomidine for Postoperative Delirium in Surgical Patients: A Mini-Review of Mechanisms, Clinical Evidence, and Practical Implementation

Provisionally accepted
Xiao-yan  LiXiao-yan LiJing-yi  YangJing-yi YangYi  QiuYi QiuCai-xia  WangCai-xia WangXiao-dong  WangXiao-dong Wang*
  • The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China

The final, formatted version of the article will be published soon.

ABSTRACT Postoperative delirium (POD) is a common acute neurocognitive disorder in the perioperative period, significantly increasing the risks of mortality and long-term functional decline. Dexmedetomidine, a highly selective α2-adrenergic receptor agonist, demonstrates potential for POD prevention through multimodal mechanisms, including sympatholytic effects, neuroinflammation attenuation, and physiological sleep preservation. Clinical evidence indicates its efficacy in reducing delirium incidence in cardiac surgery (risk ratio (RR), 0.57) and elderly non-cardiac surgical patients (RR, 0.51), though with notable population heterogeneity and risks of adverse effects such as bradycardia. Current guidelines recommend a dosing range of 0.1–0.7 μg/kg/h, yet monitoring requirements (e.g., electroencephalogram vs. hemodynamics) vary regionally. Future research should focus on precision dosing (e.g., biomarker-guided approaches), next-generation α2-agonists, and optimized multimodal strategies. The clinical application of dexmedetomidine requires careful risk-benefit assessment and integration into individualized perioperative protocols. Key words: Postoperative delirium; dexmedetomidine; clinical application; management; perspective.

Keywords: postoperative delirium, Dexmedetomidine, clinical application, Management, perspective

Received: 10 Sep 2025; Accepted: 02 Oct 2025.

Copyright: © 2025 Li, Yang, Qiu, Wang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xiao-dong Wang, xiao-dongwang@hotmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.